Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy.

Eye (London, England) - 1 Mar 2009

Brantley M A, Edelstein S L, King J M, Plotzke M R, Apte R S, Kymes S M, Shiels A

Abstract excerpt

AIM: To determine whether there is an association between complement factor H (CFH) or LOC387715 genotypes and response to treatment with photodynamic therapy (PDT) for exudative age-related macular degeneration (AMD). METHODS: Sixty-nine patients being treated for neovascular AMD with PDT were genotyped for the CFH Y402H and LOC387715 A69S polymorphisms by allele-specific digestion of PCR products. AMD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Choroidal Neovascularization
Share to Complement Factor H

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Macular Degeneration

Share to Photochemotherapy

Share to Prognosis

Share to Proteins

Share to Treatment Outcome

Share to Visual Acuity

Source

Open in PubMed Open full text

Identifiers

PMID: 18292785
DOI: 10.1038/eye.2008.28
PMCID: PMC5531276

Genes

CFH

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy.PMID 18292785Read ↗

Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.Semantic proximity Read ↗

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.Semantic proximity Read ↗

An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.Semantic proximity Read ↗

Association of complement factor H polymorphisms with exudative age-related macular degeneration.Semantic proximity Read ↗

The effect of complement factor H Y402H polymorphism on the outcome of photodynamic therapy in age-related macular degeneration.Semantic proximity Read ↗

Association between complement factor H gene polymorphisms and neovascular age-related macular degeneration in Koreans.Semantic proximity Read ↗

Neovascular age-related macular degeneration and its association with LOC387715 and complement factor H polymorphism.Semantic proximity Read ↗

Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration.Semantic proximity Read ↗

Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.Semantic proximity Read ↗

Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab.Semantic proximity Read ↗

Complement factor H Y402H polymorphism and characteristics of exudative age-related macular degeneration lesions.Semantic proximity Read ↗

Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.